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James Parkinson, in his “Essay on the Shaking Palsy” from 1817 described for the
first time the disease that later on carried his name. Its anatomical substrate remained
controversial for over 100 years. The first case that suggested the association between
Parkinson’s disease and substantia nigra was published in 1893 Blocq and Marinesco,
two scientists who worked at Salpêtrière. The article described a 38 years-old man, with
tuberculosis, who was admitted to the Charcot’s neurological ward because he also
showed signs of unilateral Parkinsonism. During the autopsy, the investigators found a
tubercle that destroyed the right substantia nigra. As the patient had overactive reflexes
on the left side and the symptomatology matched exactly the localization of the tumor,
Blocq and Marinesco suggested the Parkinsonism to be more likely a complication of
tuberculosis and not an incidental finding. In this article, we will discuss the contribution
of these two authors to the elucidation of the pathology of Parkinson’s disease, and
highlight how even a single case report may play an essential role in the development of
knowledge in biomedical sciences.
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INTRODUCTION
Parkinson’s disease, nowadays one of the most frequent and debilitating neurological disorders
(Pringsheim et al., 2014), was described for the first time at the beginning of the 19th century when
James Parkinson published his ‘‘Essay on the Shaking Palsy’’ (Parkinson, 1817). In it, Parkinson
defined the disorder as the ‘‘involuntary tremulous motion, with lessened muscular power, in parts
not in action and even when supported; with a propensity to bend the trunk forward, and to pass
from walking to a running pace; the senses and intellects being uninjured’’ (Parkinson, 1817).
Parkinson’s essay cited a few predecessors who described the disease, including Galen, Sylvius de
la Boe, Junker, or Cullen (Parkinson, 1817). All cases presented by those authors were not typical
for what we know today as Parkinson’s disease; also, none of them described the clinical aspects
of the disease in such detail as he did. The development of knowledge about Parkinson’s disease
followed four main stages (Khalil, 1996). The first one was clinical, initiated by Parkinson’s essay
and finished by the description of the rigidity as the second element of the symptomatic triad in
the 1880’s. The second stage was neuro-pathological. It started with the inquiries shepherded by
Charcot (1887) and his pupils, and ended with the works of Tretiakoff—who proved the association
between Parkinson’s disease and substantia nigra, and of Foix and Nicolesco (1925), Hassler (1938),
Greenfield and Bosanquet (1953) who showed that the changes in the pallidum are secondary.
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The third stage—neurophysiological and neurosurgical, began
with Wilson’s cortical resection (Khalil, 1996) while the fourth
was biochemical—the stage of therapeutic applications.
This article presents the case that most authors consider being
the first piece of information that led to the hypothesis about the
involvement of substantia nigra in the pathology of Parkinson’s
disease, and to summarize its consequences for the development
of knowledge in this field.
Neuropathological Findings and Theories
Before 1893
Parkinson initially suggested that the anatomical location of
the lesions causing the ‘‘shaking palsy’’ was the spinal cord:
‘‘All that had been ventured to assume here, has been that the
disease depends on a disordered state of the medulla, which
is contained in the cervical vertebrae. But of what nature that
morbid change is; and whether originating in the medulla itself,
in its membranes, or in the containing theca, is; at present, the
subject of doubt and conjecture’’ (Parkinson, 1817).
Rudolf Leubuscher, a famous German neurologist, and a
promoter of the health reform in Germany at the middle of the
19th century reported a case in which he found an association
between tremors and a fibrous tumor of the pons (Leubuscher,
1860; Ordenstein, 1868). Leopold Ordenstein, a German
neurophysiologist, and the first author to adequately differentiate
Parkinson’s disease from multiple sclerosis (Lehmann et al.,
2007) described a softening of the substantia nigra in a
patient with tremors but did not speculate upon its importance
(Ordenstein, 1868). Hughlings Jackson considered that the
morphological substrate of the disease was in the cerebellum; he
suggested a distinctive antagonism between the cerebellar and
cerebral influences, the latter causing flexion of the phalangeal
joints and the former—flexion of the metacarpophalangeal joints
(Gowers, 1896). Gowers (1896) believed that Jackson’s theory
was unfounded. He considered that the symptoms are more
likely caused by an un-antagonized cerebral influence, as ‘‘the
causes in which tremor results from organic disease of the
nervous system, we find situated, as a rule, within the cerebral
hemispheres, in the optic thalamus, posterior part of the internal
capsule, foot of the corona radiata (Nothnagel), parietal lobe of
the cortex (Chvostek), and the island of Reil (Leyden)’’ (Gowers,
1896).
A big step forward in the understanding of this disease
came from the works of Charcot (1879) at the Salpêtrière
Hospital in Paris. The works of Charcot’s and his pupils
aided in the differentiation of Parkinson’s disease from other
neurological disorders with associated tremor such as multiple
sclerosis (Charcot, 1879; Lehmann et al., 2007). Charcot
described a series of symptoms that were, as he commented,
overlooked by Parkinson, as the rigidity of the neck, trunk
and extremities (Charcot, 1879). They also showed that tremor,
bradykinesia, balance impairment, and rigidity are the four
cardinal symptoms of the disease (Gowers, 1896). Charcot was
the one who coined the term Parkinson’s disease, considering
the term paralysis agitans to be improper (Parent and Parent,
2010). However, he felt that Parkinson’s disease is a neurosis,
without a proper structural cause (Pearce, 1989), an opinion
shared by Babinski or Brissaud. In this neuropathology school
at Salpêtrière worked, amongst others, Georges Marinesco,
Paul Blocq, Edouard Brissaud or Konstantin Tretiakoff, all
involved in the discovery of the pathological substrate of the
disease.
Blocq (1860–1896) was a French neuropathology researcher
from the school of Charcot at Salpêtrière. He contributed,
amongst others, to the characterization of the astasia-abasia
syndrome (now known as Blocq’s disease; Ordenstein, 1868),
or neurasthenia and related diseases (Blocq, 1891a,b,c). His
major works were done conjointly with Georges Marinesco and
included a study on the pathogeny of essential epilepsy (Blocq
and Marinesco, 1892) where they described lesions now known
as senile plaques (Buda et al., 2009) and a famous Atlas of the
Histopathology of the Nervous System (Blocq et al., 1892). He
died young, at the age of 36.
Georges Marinesco (1863–1938, Figure 1) was one of the
most influential Romanian and European neuroscientists at the
FIGURE 1 | Georges Marinesco, in the 20’s. Personal photo collection of
author 3.
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beginning of the 20th century (Buda et al., 2013). At the end
of the 19th century, while undertaking postgraduate courses
of neurology at Salpêtrière under the supervision of Jean-
Martin Charcot, he worked with some of the most prominent
neurologists or neuropathologists of that time including Joseph
Babinski, Pierre Marie, or Paul Blocq (Buda et al., 2009). In
the last decade of the 19th century, he developed an interest
for neurodegeneration, area in which, together with Blocq, he
had outstanding contributions to the portrayal of Alzheimer’s
disease, Friederich’s ataxia, or Parkinson’s disease.
Maybe the most influential work published by Paul Blocq and
Georges Marinesco was an article published in 1893 (Figure 2).
It depicted the case of a 38 years-old man, suffering from
tuberculosis, who was admitted to the Charcot’s neurological
ward because he also displayed signs of unilateral Parkinsonism
(primarily muscle rigidity and left side tremor). Jean-Baptiste
Charcot, the son of Jean Martin Charcot, treated the patient
and detailed his clinical evolution (Parent and Parent, 2010).
The autopsy showed the cause of death to be pulmonary
FIGURE 2 | First page of the article. Public domain (article published in
1892).
complications of tuberculosis. While examining the brain, the
investigators found a tubercle that destroyed the right substantia
nigra: ‘‘Its limits in the peduncle were: in front, by the foot of
the peduncle, behind by the superior cerebellar peduncle, inward
by the fibers of the common oculomotorius nerve, and outward,
until the elements of the medial lemniscus (Untere-Schleife).
Summarizing, the tumor affected the substance of Soemmering.
It is to be remarked that various elements of the protuberance,
besides being displaced and compressed, were not destroyed, as
it was proven by the absence of degeneration of the pyramids at
the base, and of the cerebellar peduncle, at the top.’’ (Blocq and
Marinesco, 1893).
As the patient had overactive reflexes on the left side and
the symptomatology matched exactly the localization of the
tumor, Blocq and Marinesco suggested the Parkinsonism to
be more likely a complication of tuberculosis and not an
incidental finding. To support this hypothesis they cited relevant
scientific literature. For example, in an article published by
Mendel in Berliner Klinische Wochenschrift from 1885, the
author described the case of a four and a half-year-old child
with intentional tremor on the right arm, weakness of the
right ankle, paresis of the third pair of cranial nerves, the
facial, and the hypoglossal. The autopsy, in that case, revealed
a tubercle on the middle part of the cap of the left cerebral
peduncle, of the size of an almond, just beneath the subthalamus
(Blocq and Marinesco, 1893). In that case, the tremor was
intentional (intention tremor), which Charcot (1879) previously
associated with peduncle lesions. He also described a patient who
had a tumor compressing the cerebral peduncles, with associated
resting tremor and a typical, Parkinsonian pose of the upper
limbs (Blocq and Marinesco, 1893). What Blocq and Marinescu
did not do, was to pinpoint the substantia nigra as the potential
area involved in the progress of the disease. This hypothesis
was raised only a few years later by Brissaud (1895). He
analyzed the case presented by Blocq andMarinesco, emphasized
that the substantia nigra was destroyed, and suggested the
possibility it may be involved in muscle tone and may be the
anatomical substrate for Parkinson’s disease (Brissaud, 1895).
That statement received little consideration in the ensuing
decades, most pathology studies in the area focusing on the
striatum or the basal ganglia (especially lenticular fasciculus and
ansa lenticularis) (Parent and Parent, 2010). In France, Compin
(1902) supported, at the beginning of the 20th century, the
model about the nigral substrate of Parkinson’s disease. Most
researchers viewed this theory with circumspection and was
presented in scientific articles as a form of respect for Brissaud,
who coined it. The most plausible explanation at the time was
that Parkinson’s disease is not a single, clearly defined disease
but a syndrome, with different etiologies (traumatic, rheumatic,
infectious, psychiatric) (Compin, 1902). Another cause for the
fall into forgetfulness of the 1893 article was that Blocq supported
another theory about the pathogeny of Parkinson’s disease. He
was one of the most preeminent supporters of the myopathic
theory, after identifying what he considered distinguishing
muscular lesions in patients with this ailment (Fleury, 1904).
The article of Blocq and Marinesco was vastly circulated in
the first decade of the 20th century. Friederich H. Lewy, the
Frontiers in Neuroanatomy | www.frontiersin.org 3 June 2016 | Volume 10 | Article 74
Hostiuc et al. Shake the Disease
father of Lewy bodies, referenced it in an influential work from
1912: ‘‘concerning the similar structure of the cells, this could
be one coherent aggregation of cells reaching from substantia
nigra (Blocq-Marinesco found it destroyed by a tumor in a case
of shaking palsy)’’ (Lewy, 1912). As it is evident Lewy knew the
article, it remains a mystery why he did not search eosinophilic
bodies in substantia nigra until after the article of Tretiakoff
(Lewy, 1923).
The confirmation of Brissaud’s theory came in 1919, with
the thesis of Konstantin Tretiakoff. He worked at Salpêtrière in
the same laboratory with Georges Marinesco, who most likely
suggested the topic of this thesis (Lees et al., 2008). There are
no proofs to show that Blocq and Marinesco’s article led him to
examine the substantia nigra in Parkinson’s disease. Most likely
the suggestion of the theme was not made unambiguously for
Tretiakoff to explain the pathogenesis of this disorder. He should
have been aware about the hypothesis of Brissaud, as it was
heavily circulated in the circles of neuropathologists in the France
neuropathology at the start of the 20th century (Brissaud, 1895;
Fleury, 1904). It is no doubt that the article from 1893 was known
to him, and brought an additional argument for sustaining the
conclusion so clearly stated by the Russian savant: ‘‘The results
of our research lead us to say that there is an intimate relation
between the substantia nigra and Parkinson’s disease. It most
likely is a cause-effect link’’ (Lewy, 1923).
Tretiakoff drafted his thesis during the final years of the
First World War when took place an outburst of encephalitis
letargica. Constantin Alexander Economo Freiherr von San Serff,
an Austrian neuropsychiatrist, showed that patients with this
disorder had signs of Parkinson’s (von Economo, 1918). The
anatomical pathology the brain in patients with encephalitis
letargica was compared by Tretiakoff with the anatomical
pathology of the brain in Parkinson’s disease, allowing him
to draw his important conclusions. His research involved the
examination of the substantia nigra in 54 cases, of which
nine had paralysis agitans and three had postencephalitis. In
seven cases (of which six with paralysis agitans) he identified
a severe loss of pigmented nigral neurons, with edema of
the cellular bodies, gummous degeneration, and neurofibrillary
alterations. In surviving nigral cells, he identified Lewy bodies. In
people with postencephalitis, he showed the presence of severe
degeneration of the substantia nigra associated with hyaline and
granular degeneration of the surviving cells (Tretiakoff, 1919).
He concluded that changes in substantia nigra were recurrent
in patients with Parkinson’s, and were associated with vascular
pathology and various senile changes in other parts of the brain
(Fleury, 1904). The thesis of Trietiakoff was initially regarded
with disbelief. Only after a few years came the confirmation of
his results through the works of other researchers like Foix and
Nicolesco. In their monograph about the basal ganglia, published
in 1925, they confirmed that substantia nigra in patients with
Parkinson’s disease is severely altered, displaying neuronal
atrophy, neurofibrillary changes, vacuolation, and Lewy bodies
(Foix and Nicolesco, 1925).
Blocq and Marinesco presented their work during J.M
Charcot’s lifetime. The presentation of the case was done at
the Société de Biologie on 27 May 1893 when Charcot was
still actively involved in running his program at Salpêtrière.
Because Charcot held a very strict control over all material
emanating from his service, it may be hard to credit major
contributions to his students as independent investigators.
During Charcot’s leadership, Salpêtrière became one of the most
advanced centers of neuro-research in the world, through three
main activities: development of scientific and teaching facilities,
the characteristics of the staff and change in the composition
of the patient pool (Micale, 1985). The facilities, teachers, and
patients from Salpêtrière attracted numerous young, aspiring
physicians and neuro-researchers from all over the world in
the last quarter of the 19th century, leading to a high number
of scientific breakthroughs (Micale, 1985). Charcot led all his
pupils with a firm hand—each of his lectures was recorded and
published in one of the several medical journals he founded
(Ellenberger, 1970). The students worked in close collaboration
with the master—the so-called charcoterie (Micale, 1985). Even
the case published by Blocq and Marinesco was given to them
by Charcot, as they acknowledge in the introduction of the
manuscript (Blocq and Marinesco, 1893).
CONCLUSION
This short discussion regarding the etiology of Parkinson’s
disease shows how a single case report may play essential roles in
the development of knowledge in biomedical sciences. Moreover,
often the researchers who make a significant discovery, and are
brought into the spotlight, are influenced by other researchers,
with sometimes equally important roles. In the discovery
of the association between lesions of substantia nigra and
Parkinson’s disease, the article of Paul Blocq and Georges
Marinesco had an enormous indirect contribution. Both actions,
the publishing of the case report that stayed at the base
for Brissaud’s theory, and the aid given by Marinesco to
Tretiakoff in choosing his Ph.D. theme, are indirect, behind
the scenes. However, without them, the connection would
most likely be discovered much later, and subsequently, all
advances in this field might have been delayed. Therefore,
when researching the history of a scientific breakthrough,
we must also look behind the researcher who won the
spotlight and recognize the importance of the ‘‘back singers’’
too.
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